Research examining the occurrence of sexual problems in nonclinical populations tends to be restricted to highly select populations. Recently, several population-based surveys surfaced in the international literature, triggered by the advent of effective pharmacological treatment for erectile dysfunction (ED). ED is a common disorder, especially among elderly men. The annual incidence in men 40 -69 y of age is 26 per 1000 men. Although most of the difficulties are mild and do not totally prevent intercourse, about 26% of men experience moderate to complete ED. The impact of this category of ED on sexual activity among men is marked. The incidence of ED increases with age and the presence of concomitant conditions, such as diabetes mellitus, heart disease, hypertension, depression, pelvic surgery, negative mood, lack of self-esteem, problems with relationships, or just inadequate sexual experience. Vascular disease is thought to be the most common cause of organic ED, and it may be an early symptom of cardiac morbidity and mortality. Although one may expect that any man with ED who is motivated to continue sexual activity may seek current highly effective symptomatic medical treatment, only a few men are actually seeking help, and not every man seeking help appears to be a candidate for (symptomatic) medical treatment. The frequent association of sexual and medical problems, especially in the aged, and the high dropout rates for symptomatic ED treatment make counseling, adjustment of lifestyle, and modification of risk factors, such as medication, overweight, smoking, alcohol consumption, and lack of exercise, the primary steps in a holistic approach toward the treatment of ED. It is especially important to educate these men to remain physically and sexually as active as possible for as long as possible. The phrase 'use it or lose it' is particularly appropriate for the genitalia.
Introduction
Sexual problems are common in most populations and, dependent on cultural norms, they surface intermittently in the medical practice. Until the mid-1990s, population surveys examining the incidence of sexual problems were rare, and their lack of methodological rigor limits the confidence that can be placed in them. 1 Studies of the relationship between sexual problems and quality of life are virtually nonexistent. Research examining the occurrence of sexual problems in nonclinical populations tends to be restricted to highly select populations. 2 -8 Current reviews of 24 and 52 community samples reported a frequency of 0 -4% (male) and 7 -10% (female) for orgasmic disorder, 2.5 -9% for erectile problems, 0 -3% for male hypoactive sexual desire disorder, and 2.3 -5% for premature ejaculation. 1, 9, 10 Prevalence estimates obtained from primary care and sexuality clinic samples are characteristically higher.
Recently, several surveys surfaced in the international literature, triggered by the advent of effective pharmacological treatment for erectile dysfunction (ED). 11 -13 ED is a common disorder among elderly men. Although most of the difficulties are mild and do not totally prevent intercourse, about 26% of these men experience moderate to complete ED. The impact of this category of ED on sexual activity among men is marked, and it is obvious that these men seek treatment. 14 Data from the Massachusetts Male Aging Study show that the annual incidence of ED in men 40 -69 y of age is 26 per 1000 men (an incidence of 12 in the 40 -49-y age group and 46 in the 60 -69-y age group). A recent, not yet published Dutch survey indicated an annual incidence of 10.1 per 1000 men (an incidence of 8.3 in the 45 -54-y age group, 16.1 in the 55 -64-y age group, and 15.1 in the 65 -74-y age group). It is remarkable that in this survey incidence decreased in the oldest age group and doubled at the time of introduction of the first effective oral medication (sildenafil) (J Frantzen, personal communication). In the Cologne Male Survey, a prevalence of 19.2% was found with a steep age-related increase. 15 Recently, the prevalence of ED and its influence on both the quality of life and health care-seeking behavior were assessed in The Netherlands among men aged 40 -79 y with their partners. 16 The prevalence of ED increased with age class. To the question regarding whether the patient had a problem getting an erection, 13% of all men answered affirmatively (6% in the 40 -49-y age group; 9% in the 50 -59-y age group; 22% in the 60 -69-y age group; and 38% in the 70 -79-y age group). All men aged 40 -49 y with ED and 16% of men aged 70 -79 y with ED considered their ED bothersome. Thirty-four percent of all men with ED and 16% of their spouses were dissatisfied with their sex life. ED bears a strong correlation with the general quality of life and comorbidity. It is noteworthy that the lack of a sexual partner appeared to be the most prevalent and serious sexual problem for men. 8 The incidence of ED increases with the presence of concomitant conditions, such as diabetes mellitus, heart disease, hypertension, depression, pelvic surgery, negative mood, lack of self-esteem, problems with relationships, or just inadequate sexual experience. 17 -20 Vascular disease is thought to be the most common cause of organic ED, and it may be an early symptom of cardiac morbidity and mortality. 21 Greenstein et al 22 found a correlation between the severity of ischemic coronary disease and ED. There is a correspondingly above average prevalence among men treated with cardiovascular drugs and antidepressants. 23, 24 Moreover, lower urinary tract symptoms and current or previous medical treatment of benign prostatic hypertrophy correlate with the occurrence of sexual dysfunction. On closer examination, this co-occurrence is expected, since the prevalence of both conditions increases with age. 25 
Need for treatment
The likely worldwide increase in the prevalence of ED (associated with rapidly aging populations) combined with newly available and highly publicized medical treatments will raise challenging policy issues in nearly all countries. 26 However, to date, only a few men with sexual problems are seeking help, and not every man seeking help is a candidate for (symptomatic) medical treatment.
Even in an era in which sexual issues can be discussed straightforwardly, men are very secretive about their medical conditions, in particular those conditions concerned with any aspect of sexual functioning. 27 These men try to avoid public clinics, preferring to visit private clinics. Sexual problems are concealed from general practitioners, who in The Netherlands accounted for 80.8% of all sildenafil prescriptions (urologists, 13.8%; psychiatrists, 0.6%; gynecologists, 0.3%). 25 In 1998, in The Netherlands only 25% of men with ED consulted a physician, with a mean delay of 13 months, and men between 50 and 59 y of age account for most prescriptions for sildenafil (34.1%). In a broader perspective, the fact that men are less accustomed than women to receiving medical care may be the main reason for the so-called gender gap, since the difference in life expectancy is currently 7 to 8 y less for men than it is for women. 28 Current projections, which are based on the presumption that in 2025 about 322 million men worldwide will experience ED and only 1 in 3 will seek treatment, estimate that 100 million men will opt for treatment. 29 Not every man presenting with ED is a candidate for symptomatic treatment. Because of the frequent association of sexual problems and aging, ample time should be taken to educate the patient about the alterations in sexual response with aging. 30 Sexual desire, penile rigidity, and sensitivity decrease, and it takes longer for men to obtain erections. 31 Erections become more dependent on direct physical stimulation of the penis and less responsive to visual, psychologic, or nongenital excitation. Aging also affects the ejaculatory phase of the sexual response. The orgasmic muscular contractions are fewer and less intense. There is a slow but gradual decline in semen volume per ejaculation; it usually takes longer to reach ejaculation and semen may dribble out at orgasm. The sensation of ejaculatory urgency is reduced and intercourse may take place without ejaculation occurring on every occasion. The older man's refractory period during which he is unresponsive to further stimuli following orgasm gradually lengthens.
Moreover, the physician should realize that ED frequently is a sequel of a medical condition, such as vascular disease, or pharmacological agents, and most treatments are rehabilitative rather than curative. 32, 33 Therefore, important aims of treatment should be adjustment of lifestyle and modification of risk factors where possible, such as medication, overweight, smoking, alcohol consumption, and lack of exercise. 34 In this holistic medical approach, the patient should be informed that daily lifestyle decisions and practices exert a profound impact on both short-and long-term health and quality of life. Scientific and medical advances during the last 5 y have solidified the evidence that positive lifestyle measures are vitally important to good health. Medical professionals in general, and physicians in particular, occupy a uniquely powerful position from which to encourage patients to change their behaviors. In fact, in many surveys, physicians' recommendations have been shown to be the leading reason why individuals change actions and behaviors. Unfortunately, a distinct minority of physicians wield this power wisely or at all. 35 How does this knowledge relate to the field of sexual medicine? Although midlife changes may be too late to reverse the effects of lifestyle on erectile function, there is no longer any serious doubt that early adoption of a more moderate lifestyle may be the best approach to reducing the burden of ED on the health and general wellbeing of the patient 36 and that it is extremely important to educate the men to remain as active as possible for as long as possible. The phrase 'use it or lose it' is particularly appropriate for the genitalia. This is a very important message that is not always welcomed by the aging population; the best way to prevent or to limit the signs of aging is to remain active.
Adjustment of lifestyle and risk modification Medication
It is generally believed that medication-induced sexual dysfunction can significantly interfere with patients' quality of life and lead to poor compliance. 37 Drugs that interfere with hormonal, monoaminergic, adrenergic, and cholinergic mechanisms are associated with impaired sexual desire, erection, or ejaculation. However, due to several reasons, it is extremely difficult to find convincing evidence that sexual problems are drug related. First, not much is known about pharmacological mechanisms and the frequency of ED as an adverse effect of medication. Furthermore, the limited access to valid pharmacoepidemiological data is a major drawback. Forman et al 38 were only able to access information in the public domain. Two important sources of valuable data are not available to the public. These are databases collated by the Committee on Safety of Medicines via the yellow card notification scheme and those held by the pharmaceutical manufacturers. Manufacturers have a reporting obligation to notify the Committee on Safety of Medicines about serious or life-threatening adverse effects. Sexual dysfunction does not come into this category. 38 Moreover, when an association between drug consumption and sexual dysfunction is present, confounding variables, such as lifestyle and the use of other drugs, may prevent conclusions about causality. Finally, patients may willingly report socially acceptable adverse effects such as nausea, lethargy, or headaches, but there is increasing evidence that they may not volunteer information about sexual dysfunction.
How then to proceed when ED seems to be an adverse effect of medication? A causal relationship may be suspected if the onset of ED coincides with the start of the medication use. In most cases, however, a causal relationship remains unclear. If a strong suspicion remains, a change of medication, lowering of dose, or a 'drug holiday' may yield a positive result.
Obesity
The association between obesity and illness was initially alluded to by Hippocrates, who observed that 'When more food than is proper has been taken, it occasions disease.' In the Massachusetts Male Aging Study, overweight (body mass index, 28) almost doubled the incidence of ED at follow-up. 39 Obesity, defined as a body mass index of more than 30, is a condition that is reaching epidemic proportions not only in the developed but also in the developing world. The body mass index is defined as body weight in kilograms divided by the square of height in meters. Normal weight is represented by a value between 18 and 25, whereas values between 25 and 30 indicate overweight. Obesity is associated with adverse lipid profiles, hypertension, and diabetes and may be independently associated with coronary heart disease. 40, 41 Sixty-three percent of US men and 55% of US women are overweight. Twenty-two percent are grossly overweight, with a body mass index of more than 30. The frequency of overweight is maximal between the ages of 50 and 60 y and shows a subsequent tendency to decline slowly. 42 The prevalence of obesity has doubled in the past decade. 43 The consequences are serious. Approximately 80% of obese adults have at least one and 40% have two or more associated diseases, such as diabetes, hypertension, cardiovascular disease, gall bladder disease, cancers, and the morbidity of diseases of the locomotor system such as osteoarthrosis. The literature is unequivocal about the relationship between ED and obesity. Derby et al 36 found the obesity status, regardless of followup weight loss, to be associated with ED. Chung et al, 44 however, demonstrated that obesity in itself is not an underlying risk factor, but does impose a risk by causing vascular disease.
Smoking
There is a wealth of clinical and experimental evidence that smoking and ED are closely related. The risk of ED caused by atherosclerosis of the internal pudendal artery is a third higher in smokers than nonsmokers. 44 Penile Doppler ultrasonographic studies in smokers and nonsmokers show a reduced erectile response and a reduced increase in blood flow velocity in smokers following pharmacological stimulation. 45 Heavy smokers have the fewest minutes of nocturnal tumescence and experienced detumescence fastest. 46 Moreover, smokers show not only lower penile brachial pressure index
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EJH Meuleman values but also higher incidence of an incomplete response to papaverine injection than nonsmokers. 47 Animal experiments indicate that long-term smoking leads to age-independent decreases in penile nitric oxide synthase activity. 48 In the Massachusetts Male Aging Study, cigarette smoking almost doubled the risk of developing moderate to severe ED at follow-up (24 vs 14%). Cigar smoking and passive exposure to cigarette smoke also significantly predicted incident ED. Cigarette smoking has consistently and in a dose-related manner been shown to be related to the development of atherosclerosis. 49 -51 On the other hand, cigarette smoking has not been shown to be a potent risk factor for the sequels of atherosclerosis in a population such as the Japanese, who are characterized by low serum cholesterol levels. These observations, in conjunction with results from studies that have shown a markedly decreased risk after quitting smoking, with the excess risk of atherosclerosis declining relatively quickly after quitting, suggest that smoking may act as a triggering agent rather than a necessary and sufficient factor. 52, 53 Passive exposure to secondary cigarette smoke has been associated with clinically manifest and subclinical atherosclerosis and carotid atherosclerosis through a number of pathophysiological mechanisms. 54, 55 Although the relative risks associated with passive smoking are less than those attributed to direct inhalation, the large proportion of the population exposed to environmental tobacco smoke suggests that the adverse health consequences for a large number of persons may be affected by even small increases in the risk of coronary disease and possibly selected cancers.
Alcohol
The effects of alcohol consumption were well known to Shakespeare, who commented in Macbeth that alcohol 'provokes the desire but takes away the performance.' Shakespeare's observations were based on anecdotal evidence but have been confirmed in the laboratory setting. When penile erection and vaginal vasocongestion following visual erotic stimulation are measured, the subjective impression of sexual arousal is increased, whereas the objectively measured response is reduced following alcohol consumption. 56, 57 Alcohol also causes orgasmic delay in women 58 and depresses testosterone concentrations in men following shortterm ingestion. 59 In the UK, 27% of men drink more than the recommended limit of 3 -4 units per day. 60 The effects of alcohol on sexual function can be divided into those that result from short-term alcohol consumption by otherwise healthy individuals (social drinking) and those secondary to chronic alcoholism. The latter effects are not just caused by the pharmacological effects of ethanol but are compounded by secondary systemic disturbances induced by alcohol, including liver disease, malnutrition, and domestic disharmony. Consumption of alcohol has not been shown to lead to an increased risk of atherosclerosis, and a substantial body of evidence indicates that moderate alcohol intake is associated with a reduced risk of developing and dying from atherosclerosis. Most studies examining the association between alcohol use and atherosclerosis have suggested either a negative or a U-shaped relation. 61 In patients with chronic alcoholism, the sexual dysfunction is related to the quantity, frequency, and duration of drinking. Additionally, the drinking pattern appears to be of importance: heavy drinkers more often experience pancreatitis, esophageal varices, polyneuropathy, or ED than episodic drinkers. Thus, the drinking pattern, particularly frequent inebriation, has an influence on the occurrence of alcohol-related disorders. 62 One study showed that 59% of men attending an alcoholism program experienced ED and 48% had difficulties with ejaculation during bouts of heavy drinking. 63 Chronic alcoholism may result in permanent impotence even after the complete cessation of drinking for many years. 64 
Exercise
In a longitudinal survey (n ¼ 1156; average followup, 8.8 y) physical activity was associated with ED, with the highest risk among men who remained sedentary and the lowest among those who remained active or initiated physical activity. 34 The results suggest that sedentary men may be able to reduce their risk of ED by adopting regular physical activity at a level of at least 200 kcal=day, which corresponds to walking briskly for 3.5 km. 65 In an Australian survey, among 427 men older than 40 y, a history of vigorous exercise was protective against ED across all ages. 66 
Symptomatic treatment
To date, the effectiveness of medications and the availability of vacuum devices and penile prostheses have ensured that anyone who is motivated to continue sexual activity may do so. However, given the high dropout rates for symptomatic ED treatment (oral medication, 45%) (PC Souverein, personal communication), patient education and counseling should remain the cornerstones in any ED treatment.
Preferred 
Conclusion
ED is a common disorder among elderly men: the annual incidence of ED in men older than 45 y in The Netherlands is 10.1 per 1000 men. The incidence of ED depends on the availability of treatment options and increases with age and the presence of concomitant conditions, such as diabetes mellitus, heart disease, hypertension, depression, negative mood, lack of self-esteem, problems with relationships, or just inadequate sexual experience. Although there is a wealth of information regarding risk factors contributing to the development of ED and given the fact that current symptomatic treatments are invasive, are costly, or have unproved long-term benefits, in daily practice too little attention is paid to the modification of risk factors and secondary prevention. A more physically active lifestyle, quitting smoking, reduction of overweight, and a moderate alcohol intake may be viewed as integral components of a comprehensive ED risk reduction program. Given the high dropout rates for symptomatic ED treatment, patient education and counseling should be the cornerstones of any ED treatment.
the idea that 'I have to get aroused in this situation with my partner.' Dr Porst: I have some general problems in understanding the epidemiological data worldwide. You know that the Pfizer Company has conducted worldwide epidemiological questionnaires. They were also done in some countries of Africa, where these populations will reach a mean age of between 40 and 50 y. What we saw at this mean age was an incidence of erectile dysfunction between 30% and 50%. Although we have a very high incidence of erectile dysfunction in these developing countries, this population does not have as many risk factors as we have at 60 to 70 y of age? How does this fit in with our view of increasing age and risk factors? Dr Hatzichristou: A study has shown that 17% of those reported to be sexually active did not have erections, but they didn't care about erections. They were very happy with sexual activity other than penetration, and they reported that they were sexually active 2 or 3 times per week. So we should consider all the studies, even those addressing cultural issues. For example, in Africa, having intercourse 3 or 4 times per day is possibly normal. So if someone could not perform more than once a day, is he impotent? We need to consider those cultural and age-related issues. Dr Wespes: In Belgium we have a lot of African patients because of the Congo. Sometimes these patients seek treatment because they cannot have erections three times in 2 hours. I tell them, I am impotent, you are potent. This is the cultural difference.
